Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003.

Maaland AF, Heyerdahl H, O'Shea A, Eiriksdottir B, Pascal V, Andersen JT, Kolstad A, Dahle J.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2311-2321. doi: 10.1007/s00259-019-04417-1. Epub 2019 Jul 15.

2.

Fertility desires and reproductive needs of transgender people: Challenges and considerations for clinical practice.

Feigerlová E, Pascal V, Ganne-Devonec MO, Klein M, Guerci B.

Clin Endocrinol (Oxf). 2019 Jul;91(1):10-21. doi: 10.1111/cen.13982. Epub 2019 Apr 17. Review.

PMID:
30943314
3.

Altered host-gut microbes symbiosis in severely malnourished anorexia nervosa (AN) patients undergoing enteral nutrition: An explicative factor of functional intestinal disorders?

Hanachi M, Manichanh C, Schoenenberger A, Pascal V, Levenez F, Cournède N, Doré J, Melchior JC.

Clin Nutr. 2019 Oct;38(5):2304-2310. doi: 10.1016/j.clnu.2018.10.004. Epub 2018 Oct 9.

PMID:
30527539
4.

Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy.

Chakraborty M, Sellier C, Ney M, Pascal V, Charlet-Berguerand N, Artero R, Llamusi B.

Dis Model Mech. 2018 Apr 23;11(4). pii: dmm032557. doi: 10.1242/dmm.032557. Erratum in: Dis Model Mech. 2018 May 18;11(5):.

5.

A microbial signature for Crohn's disease.

Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C.

Gut. 2017 May;66(5):813-822. doi: 10.1136/gutjnl-2016-313235. Epub 2017 Feb 7.

6.

Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.

Lamberth K, Reedtz-Runge SL, Simon J, Klementyeva K, Pandey GS, Padkjær SB, Pascal V, León IR, Gudme CN, Buus S, Sauna ZE.

Sci Transl Med. 2017 Jan 11;9(372). pii: eaag1286. doi: 10.1126/scitranslmed.aag1286.

PMID:
28077675
7.

MetaTrans: an open-source pipeline for metatranscriptomics.

Martinez X, Pozuelo M, Pascal V, Campos D, Gut I, Gut M, Azpiroz F, Guarner F, Manichanh C.

Sci Rep. 2016 May 23;6:26447. doi: 10.1038/srep26447.

8.

IgA Structure Variations Associate with Immune Stimulations and IgA Mesangial Deposition.

Oruc Z, Oblet C, Boumediene A, Druilhe A, Pascal V, Le Rumeur E, Cuvillier A, El Hamel C, Lecardeur S, Leanderson T, Morelle W, Demengeot J, Aldigier JC, Cogné M.

J Am Soc Nephrol. 2016 Sep;27(9):2748-61. doi: 10.1681/ASN.2015080911. Epub 2016 Jan 29.

9.

Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.

Nielsen N, Pascal V, Fasth AE, Sundström Y, Galsgaard ED, Ahern D, Andersen M, Baslund B, Bartels EM, Bliddal H, Feldmann M, Malmström V, Berg L, Spee P, Söderström K.

Immunology. 2014 Aug;142(4):581-93. doi: 10.1111/imm.12271.

10.

Anti-NKG2A autoantibodies in a patient with systemic lupus erythematosus.

Hagberg N, Theorell J, Eloranta ML, Pascal V, Bryceson YT, Rönnblom L.

Rheumatology (Oxford). 2013 Oct;52(10):1818-23. doi: 10.1093/rheumatology/ket220. Epub 2013 Jul 3.

PMID:
23825044
11.

Improving plant functional groups for dynamic models of biodiversity: at the crossroads between functional and community ecology.

Isabelle B, Pauline P, Sylvain A, Roland D, Luc G, Sébastien L, Sandra L, Jérémie VE, Pascal V, Wilfried T.

Glob Chang Biol. 2012 Nov 1;18(11). doi: 10.1111/j.1365-2486.2012.02783.x.

12.

Class-specific effector functions of therapeutic antibodies.

Pascal V, Laffleur B, Cogné M.

Methods Mol Biol. 2012;901:295-317. doi: 10.1007/978-1-61779-931-0_19.

PMID:
22723109
13.

Production of human or humanized antibodies in mice.

Laffleur B, Pascal V, Sirac C, Cogné M.

Methods Mol Biol. 2012;901:149-59. doi: 10.1007/978-1-61779-931-0_9.

PMID:
22723099
14.

Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells.

Pascal V, Laffleur B, Debin A, Cuvillier A, van Egmond M, Drocourt D, Imbertie L, Pangault C, Tarte K, Tiraby G, Cogné M.

Haematologica. 2012 Nov;97(11):1686-94. doi: 10.3324/haematol.2011.061408. Epub 2012 Jun 11.

15.

Glycotranscriptome study reveals an enzymatic switch modulating glycosaminoglycan synthesis during B-cell development and activation.

Duchez S, Pascal V, Cogné N, Jayat-Vignoles C, Julien R, Cogné M.

Eur J Immunol. 2011 Dec;41(12):3632-44. doi: 10.1002/eji.201140865. Epub 2011 Nov 10.

16.

Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia.

Coulon S, Dussiot M, Grapton D, Maciel TT, Wang PH, Callens C, Tiwari MK, Agarwal S, Fricot A, Vandekerckhove J, Tamouza H, Zermati Y, Ribeil JA, Djedaini K, Oruc Z, Pascal V, Courtois G, Arnulf B, Alyanakian MA, Mayeux P, Leanderson T, Benhamou M, Cogné M, Monteiro RC, Hermine O, Moura IC.

Nat Med. 2011 Oct 23;17(11):1456-65. doi: 10.1038/nm.2462.

PMID:
22019886
17.

Decreased bone mineral density in adult patients with muscular dystrophy.

Philippe V, Pruna L, Abdel Fattah M, Pascal V, Kaminsky P.

Joint Bone Spine. 2011 Dec;78(6):651-2. doi: 10.1016/j.jbspin.2011.05.006. Epub 2011 Jul 2. No abstract available.

PMID:
21727019
18.

Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation.

Duchez S, Amin R, Cogné N, Delpy L, Sirac C, Pascal V, Corthésy B, Cogné M.

Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3064-9. doi: 10.1073/pnas.0912393107. Epub 2010 Jan 28.

19.

[Transgenesis and humanization of murine antibodies].

Cogné M, Duchez S, Pascal V.

Med Sci (Paris). 2009 Dec;25(12):1149-54. doi: 10.1051/medsci/200925121149. Review. French.

20.

Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.

Li H, Pascal V, Martin MP, Carrington M, Anderson SK.

PLoS Genet. 2008 Nov;4(11):e1000254. doi: 10.1371/journal.pgen.1000254. Epub 2008 Nov 14.

21.

Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire.

Whittaker GC, Burshtyn DN, Orr SJ, Quigley L, Hodge DL, Pascal V, Zhang W, McVicar DW.

Blood. 2008 Oct 1;112(7):2869-77. doi: 10.1182/blood-2007-11-121590. Epub 2008 Jul 21.

22.

A mutation in KIR3DS1 that results in truncation and lack of cell surface expression.

Martin MP, Pascal V, Yeager M, Phair J, Kirk GD, Hoots K, O'Brien SJ, Anderson SK, Carrington M.

Immunogenetics. 2007 Oct;59(10):823-9. Epub 2007 Aug 9. Erratum in: Immunogenetics. 2007 Oct;59(10):831.

PMID:
17687550
23.

NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells.

Pascal V, Nathan NR, Claudio E, Siebenlist U, Anderson SK.

J Immunol. 2007 Aug 1;179(3):1751-9.

24.

Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection.

Pascal V, Yamada E, Martin MP, Alter G, Altfeld M, Metcalf JA, Baseler MW, Adelsberger JW, Carrington M, Anderson SK, McVicar DW.

J Immunol. 2007 Aug 1;179(3):1625-33.

25.

Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.

Berthet C, Rodriguez-Galan MC, Hodge DL, Gooya J, Pascal V, Young HA, Keller J, Bosselut R, Kaldis P.

Mol Cell Biol. 2007 Jul;27(14):5079-89. Epub 2007 May 7.

26.

Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1.

Ivanova AV, Ivanov SV, Pascal V, Lumsden JM, Ward JM, Morris N, Tessarolo L, Anderson SK, Lerman MI.

J Pathol. 2007 Apr;211(5):591-601.

PMID:
17318811
27.
28.

Heterogeneity of anti-beta2-glycoprotein I antibodies. A factor of variability in test results.

Sanmarco M, Bardin N, Blank M, Pascal V, Christine Alessi M, Dignat-George F, Shoenfeld Y, Harlé JR.

Thromb Haemost. 2005 Jan;93(1):80-7. Erratum in: Thromb Haemost. 2005 Apr;93(4):796-7.

PMID:
15630495
29.

Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions.

Pascal V, Schleinitz N, Brunet C, Ravet S, Bonnet E, Lafarge X, Touinssi M, Reviron D, Viallard JF, Moreau JF, Déchanet-Merville J, Blanco P, Harlé JR, Sampol J, Vivier E, Dignat-George F, Paul P.

Eur J Immunol. 2004 Oct;34(10):2930-40.

30.

Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.

Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH, Lockett SJ, Abshari M, Anderson SK.

Immunity. 2004 Jul;21(1):55-66.

31.

A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells.

Bernard F, Picard C, Cormier-Daire V, Eidenschenk C, Pinto G, Bustamante JC, Jouanguy E, Teillac-Hamel D, Colomb V, Funck-Brentano I, Pascal V, Vivier E, Fischer A, Le Deist F, Casanova JL.

Pediatrics. 2004 Jan;113(1 Pt 1):136-41.

PMID:
14702466
32.

A CD4+ V(beta)13.6+ CD56+ large granular lymphocyte expansion with decreased expression of CD95 and an indolent clinical course.

Schleinitz N, Brunet C, Pascal V, Potie C, Veit V, Paul P, Dignat-George F, Harle JR.

Haematologica. 2002 Nov;87(11):ECR35. No abstract available.

PMID:
12414361
33.

Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation.

Pascal V, Brunet C, Pradel V, Thirion X, Andre P, Faucher C, Sampol J, Dignat-George F, Blaise D, Vivier E, Chabannon C.

Leukemia. 2002 Nov;16(11):2259-66.

34.

Biology of T memory type 1 cells.

Anfossi N, Pascal V, Vivier E, Ugolini S.

Immunol Rev. 2001 Jun;181:269-78. Review.

PMID:
11513148
35.

Lead poisoning secondary to hyperthyroidism: report of two cases.

Klein M, Barbé F, Pascal V, Weryha G, Leclère J.

Eur J Endocrinol. 1998 Feb;138(2):185-8.

PMID:
9506864
36.

A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain.

Hoffman M, Xu JC, Smith C, Fanelli C, Pascal V, Degaetano C, Meenan G, Lehrer M, Lesser M, Citron M.

Cancer Invest. 1997;15(6):542-7.

PMID:
9412659
37.

[Heart and thyroid].

Klein M, Pascal V, Aubert V, Weryha G, Danchin N, Leclére J.

Ann Endocrinol (Paris). 1995;56(5):473-86. Review. French.

PMID:
8597489
38.

Nucleotide sequence analysis of rheumatoid factors and polyreactive antibodies derived from patients with rheumatoid arthritis reveals diverse use of VH and VL gene segments and extensive variability in CDR-3.

Pascal V, Viktor K, Randen I, Thompson K, Steinitz M, Førre O, Fu SM, Natvig JB, Capra JD.

Scand J Immunol. 1994 Jul;40(1):125. No abstract available.

PMID:
8029638
39.

[Undifferentiated osteogenic carcinoma of the thyroid].

Lindas P, Pigret D, Mayot D, Pascal V, Brunet A, Floquet J, Weryha G, Perrin C.

Ann Otolaryngol Chir Cervicofac. 1994;111(3):169-72. French.

PMID:
7840490
40.

[Value of ketoconazole in the treatment of Cushing disease].

Pascal V, Denet S, Weryha G, Kaminski P, Leclère J, Hartemann P.

Rev Med Interne. 1993 Jan;14(1):58-61. Review. French.

PMID:
8362113
41.

[Epidemiology].

Leclere J, Weryha G, Pascal V, Duquenne M, Duriez T.

Ann Endocrinol (Paris). 1993;54(4):213-7. Review. French. No abstract available.

PMID:
8092788
42.

[Unusual association of anterior pituitary insufficiency and differentiated thyroid cancer].

Amiot F, Denet S, Pascal V, Hartemann P.

Presse Med. 1991 Feb 9;20(5):220-1. French. No abstract available.

PMID:
1826154
43.

[Treatment of functional menorrhagia and metrorrhagia with para-oxypropiophenone].

PASCAL V, SUCHAR A, GEORGESCO I.

C R Soc Fr Gyncol. 1957 Jun-Sep;27(6):271-2. French. No abstract available.

PMID:
13490003

Supplemental Content

Loading ...
Support Center